Home/Filings/4/0001179110-21-010095
4//SEC Filing

Veness Adam M 4

Accession 0001179110-21-010095

CIK 0001280600other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:15 PM ET

Size

6.6 KB

Accession

0001179110-21-010095

Insider Transaction Report

Form 4
Period: 2021-11-09
Veness Adam M
VP, General Counsel and Sec.
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-09$29.37/sh+4,500$132,16523,423 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2021-11-094,5000 total
    Exercise: $29.37Exp: 2024-08-01Common Stock (4,500 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vested as to 25% of the shares on July 14, 2015 and the remaining shares vested in equal quarterly installments over the following three years thereafter.

Issuer

ACCELERON PHARMA INC

CIK 0001280600

Entity typeother

Related Parties

1
  • filerCIK 0001778623

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:15 PM ET
Size
6.6 KB